CRIS FY 2024 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena

CRISCuris, Inc.

$15M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$11M+8.8% YoY

Gross Profit

$11M99.1% margin

Operating Income

-$45M-408.3% margin

Net Income

-$43M-397.8% margin

EPS (Diluted)

$-6.88

Cash Flow

Operating Cash Flow

-$40M

Free Cash Flow

-$40M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$41M

Total Liabilities

$47M

Stockholders' Equity

-$6M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$10M	+8.8%
Gross Profit	$11M	$10M	+10.2%
Operating Income	-$45M	-$48M	+7.8%
Net Income	-$43M	-$47M	+8.5%